ONC.TO : Summary for ONCOLYTICS BIO - Yahoo Finance

U.S. Markets close in 5 hrs 7 mins

Oncolytics Biotech Inc. (ONC.TO)


Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
0.79-0.08 (-9.20%)
As of 10:30AM EDT. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.87
Open0.85
Bid0.78 x
Ask0.79 x
Day's Range0.78 - 0.87
52 Week Range0.19 - 1.13
Volume187,919
Avg. Volume329,564
Market Cap95.79M
Beta2.24
PE Ratio (TTM)-6.27
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Groupyesterday

    Oncolytics Biotech® Inc. Announces Details of 2017 Annual Meeting of Shareholders

    Oncolytics Biotech® Inc. Announces Details of 2017 Annual Meeting of Shareholders

  • PR Newswireyesterday

    Oncolytics Biotech® Inc. Announces Details of 2017 Annual Meeting of Shareholders

    CALGARY, April 27, 2017 /PRNewswire/ - Oncolytics Biotech® Inc. (Oncolytics or the Company) (ONC.TO) (ONCYF) announced today that its 2017 Annual Meeting of Shareholders will be held on Thursday, May 4th, 2017 at 4:00 pm ET (2:00 pm MT) at the Toronto Region Board of Trade located at First Canadian Place, Suite 350, 77 Adelaide Street West, Toronto, Ontario. Following the business portion of the meeting, Dr. Matt Coffey, President and CEO of Oncolytics, will discuss recent progress in the development of REOLYSIN®, including recent randomized phase 2 metastatic breast cancer results as well as the detailed clinical development plan and specific initial registration pathway for REOLYSIN. A live audio webcast of Dr. Coffey's presentation will begin at approximately 4:15 pm ET (2:15 pm MT) and be available at http://event.on24.com/r.htm?e=1415093&s=1&k=1D9EC98BC2D829CD19D1A85F7769DEAC and on the company's website at http://www.oncolyticsbiotech.com/investor-centre/presentations.

  • Accesswire2 days ago

    Research Reports Initiated on Healthcare Stocks: Cardiome Pharma, Immunovaccine, Oncolytics Biotech, and Aeterna Zentaris

    LONDON, UK / ACCESSWIRE / April 26, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected ...